Norges Bank Adicet Bio, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.21 - $2.4 $519,755 - $1.03 Million
429,550 New
429,550 $519,000
Q4 2023

Feb 09, 2024
BUY
$1.11 - $1.89 $476,800 - $811,849
429,550 New
429,550 $811,000
Q3 2023

Nov 13, 2024
BUY
$1.37 - $3.4 $588,483 - $1.46 Million
429,550 New
429,550 $588,000

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $36M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email